Replies to post #8176 on Tasty Booshers

[Estimated_Prophet]

Mike and Waverider, thanks for the APYM comments, that is one lofty revenue projection, and the stock should be at $10 now if true.

Mike,

BIPH, technically speaking, it is a great entry at 1.36-1.42. If you were to stick to the technicals, I think they would fall apart around 10% down from here. So, if you plan on sticking with the technicals to guide the position, I would see what a 10% loss from here makes you feel, if you can handle it, then I think the upside is huge. This is typically a great risk/reward entry on major breakouts like BIPH is starting to develope.

[RedShoulder]

Mikeo, that BIPH webcast has me looking at other holdings to roll over into BIPH. Glad I rolled ALMI into BIPH after hearing the latest details from the BIPH CEO. BIPH is the best stock I have looked at in years for a potential big winner IMHO, and at a bargain entry price. Nice to see the technicals line up with the coming BIPH news, regarding at least two partnerships in the final stages of contract negotiations. One is BSX for stents, and other products needing BIPH IP. I am speculating the other is Medtronic for MRI safe and imageable pacemakers. Term sheet already agreed upon in at least one of these cases (likely BSX).
On the stents alone, it sounds like at least 4% royalties on BSX stents, which would come out to be about $120M annually for BIPH, with 80% margin profit. That's just one product, from one medical devise maker, BSX is interested in multiple products per BIPH Jan 10QSB. Then there is the pacemaker market...
The webcast is well worth the effort to hear,... too many good details to list here.
GLTY Mikeo.
... %^ greeneyedhawk